Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ningmitai capsule for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) – randomized double-blind placebo-controlled phase II trial
CTR20250579Phase 2Active
- Sponsor
- Guiyang Xintian Pharmaceutical Co., Ltd.
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ningmitai in Prostatodynia (CP/CPPS), sponsored by Guiyang Xintian Pharmaceutical Co., Ltd.. Started Jun 2025; status: active.
02
Drugs
ningmitai
03
Conditions
Prostatodynia (CP/CPPS)
Beyond the preview
Go deeper on CTR20250579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250579.